Senseonics to Present at the Inaugural Gilmartin Group Emerging Growth Company ShowcaseBusiness Wire • 08/17/22
Senseonics Holdings, Inc. (SENS) CEO Tim Goodnow on Q2 2022 Results - Earnings Call TranscriptSeeking Alpha • 08/10/22
Senseonics Holdings (SENS) Reports Q2 Loss, Tops Revenue EstimatesZacks Investment Research • 08/10/22
Senseonics Announces a Positive Coverage Decision for Eversense® E3 CGM from AnthemBusiness Wire • 08/03/22
Senseonics Holdings, Inc. Schedules Second Quarter 2022 Earnings Release and Conference Call for August 9, 2022, at 4:30 p.m. Eastern TimeBusiness Wire • 07/26/22
Senseonics Announces CE Mark Approval of the Eversense E3 Continuous Glucose Monitoring SystemBusiness Wire • 06/16/22
Senseonics to Participate in the H.C. Wainwright Global Investment ConferenceBusiness Wire • 05/16/22
Senseonics Holdings, Inc. (SENS) CEO Tim Goodnow on Q1 2022 Results - Earnings Call TranscriptSeeking Alpha • 05/11/22
Senseonics Holdings, Inc. Schedules First Quarter 2022 Earnings Release and Conference Call for May 10, 2022, at 4:30 p.m. Eastern TimeBusiness Wire • 04/26/22
Senseonics Announces the First Patient Implant of the Eversense E3 CGM System in the U.S.Business Wire • 04/06/22
Senseonics Holdings (SENS) Beats Q4 Earnings and Revenue EstimatesZacks Investment Research • 03/02/22
Senseonics Holdings, Inc. (SENS) CEO Tim Goodnow on Q4 2021 Results - Earnings Call TranscriptSeeking Alpha • 03/02/22
Senseonics Holdings, Inc. Reports Fourth Quarter and Full Year 2021 Financial ResultsBusiness Wire • 03/01/22